Effect of L-NAME on nitric oxide and gastrointestinal motility alterations in cirrhotic rats

被引:0
|
作者
Wang, X
Zhong, YX
Zhang, ZY
Lu, J
Lan, M
Miao, JY
Guo, XG
Shi, YQ
Zhao, YQ
Ding, J
Wu, KC
Pan, BR
Fan, DM [1 ]
机构
[1] Military Med Univ 4, Xijing Hosp, Inst Digest Dis, Shaanxi 710033, Peoples R China
[2] Military Med Univ 4, Tangdu Hosp, Emergency Dept, Shaanxi 710038, Peoples R China
[3] Tsinghua Univ, Dept Elect Engn, Beijing 100084, Peoples R China
[4] Fourth Mil Med Univ, Xijing Hosp, Oncol Ctr, Xian 710032, Peoples R China
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To investigate the effect of L-NAME on nitric oxide and gastrointestinal motility alterations in cirrhotic rats. METHODS: Rats with cirrhosis induced by carbon tetrachloride were randomly divided into two groups, one( n = 13) receiving 0. 5 mg . kg(-1) per day of N-G-nitro-L-arginine methyl ester (L-NAME), a nitric oxide synthase inhibitor, for 10 days, whereas the other group ( n = 13) and control ( n = 10) rats were administrated the same volume of 9 g . L-1 saline. Half gastric emptying time and 2 h residual rate were measured by SPECT, using (99m) Tc-DTPA-labeled barium sulfate as test meal. Gastrointestinal transition time was recorded simultaneously. Serum concentration of nitric oxide ( NO) was determined by the kinetic cadmium reduction and colorimetric methods. Immunolhistochemical SABC method was used to observe the expression and distribution of three types of nitric oxide synthase (NOS) isoforms in the rat gastrointestinal tract. Western blot was used to detect expression of gastrointestinal NOS isoforms. RESULTS: Half gastric emptying time and transgastrointestinal time were significantly prolonged( 124. 0 +/- 26. 4 min; 33.7 +/- 8.9 min;72.1 +/- 15.3 min; P < 0.01), (12.4 +/- 0.5 h; 9.5 +/- 0.3 h; 8.2 +/- 0.8 h; P < 0. 01), 2 h residual rate was raised in cirrhotic rats than in controls and cirrhotic rats treated with L-NAME(54.9 +/- 7.6 %,13.7 +/- 3.2 %, 34.9 +/- 10.3 %, P < 0.01). Serum concentration of NO was significantly increased in cirrhotic rats than in the other groups (8.20 +/- 2.48) mumol . L-1, (5.94 +/- 1.07) mumol . L-1, and control (5.66 +/- 1.60) mumol . L-1, P < 0.01. NOS staining intensities which were mainly located in the gastrointestinal tissues were markedly lower in cirrhotic rats than in the controls and cirrhotic rats after treated with L-NAME. CONCLUSION: Gastrointestinal motility was remarkably inhibited in cirrhotic rats, which could be alleviated by L-NAME. Nitric oxide may play an important role in the inhibition of gastrointestinal motility in cirrhotic rats.
引用
收藏
页码:328 / 332
页数:5
相关论文
共 50 条
  • [21] The nitric oxide synthesis inhibitor L-NAME facilitates associative learning
    Du, W
    Harvey, JA
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1996, 20 (07): : 1183 - 1195
  • [22] Cardiomyoctye hypertrophy following inhibition of nitric oxide synthase by l-NAME
    Bell, D
    Kelso, EJ
    Rush, L
    Lamont, V
    McDermott, BJ
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2004, 36 (05) : 715 - 715
  • [23] L-NAME, a nitric oxide synthase inhibitor, modulates cholinergic antinociception
    Jain, NK
    Kulkarni, SK
    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 1999, 21 (03): : 161 - 165
  • [24] Effects of the nitric oxide donor (L-ARGININE) and nitric oxide synthase inhibitor (L-NAME) on reactivity of the central dopamine (DA) receptors in rats
    Brus, R
    Kasperska, A
    Nowak, P
    Szkilnik, R
    Kostrzewa, RM
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R95 - R95
  • [25] EFFECTS OF BARAKOL AND NITRIC OXIDE SYNTHASE INHIBITOR, L-NAME ON THE OPEN FIELD BEHAVIOR OF STRESS RATS
    Wongwitdecha, N.
    Soo-ampon, S.
    Rittilert, P.
    Verawatnapakul, V.
    JOURNAL OF NEUROCHEMISTRY, 2009, 110 : 48 - 48
  • [26] Repeated administration of the nitric oxide synthase inhibitor L-NAME differentially affects rats' recognition memory
    Georgiadou, Georgia
    Pitsikas, Nikolaos
    BEHAVIOURAL BRAIN RESEARCH, 2011, 224 (01) : 140 - 144
  • [27] Inhibition of nitric oxide synthase by L-NAME improves ventricular performance in streptozotocin-diabetic rats
    Smith, JM
    Paulson, DJ
    Romano, FD
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1997, 29 (09) : 2393 - 2402
  • [28] Nitric oxide synthase inhibition by L-NAME in streptozotocin induced diabetic rats:: Impacts on oxidative stress
    Seven, A
    Güzel, S
    Seymen, O
    Civelek, S
    Bolayirli, M
    Yigit, G
    Burçak, G
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 199 (04): : 205 - 210
  • [29] DECREASED TOLERANCE TO HYPEROXIA IN NEWBORN RATS TREATED WITH THE NITRIC-OXIDE SYNTHASE INHIBITOR, L-NAME
    PIERCE, MR
    VOELKER, CA
    SOSENKO, IRS
    OLISTER, SM
    CLARK, DA
    MILLER, MJS
    PEDIATRIC RESEARCH, 1995, 37 (04) : A345 - A345
  • [30] L-name, a nitric oxide synthase inhibitor, as a potential countermeasure to post-suspension hypotension in rats
    Bayorh, MA
    Socci, RR
    Watts, S
    Wang, M
    Eatman, D
    Emmett, N
    Thierry-Palmer, M
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 2001, 23 (08) : 611 - 622